| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q5JVC1 | Citrate lyase subunit beta-like protein, mitochondrial; Fragment; | CLYBL; | NULL | 147 | human |
| A0A024R872 | Chromosome 9 open reading frame 88, isoform CRA_a; | C9orf88; | NULL | 733 | human |
| H0YGY9 | tRNA 2'-phosphotransferase 1; Fragment; | TRPT1; | NULL | 115 | human |
| A0A024R601 | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant, isoform CRA_a; | CLN6; | NULL | 311 | human |
| H0YLD0 | Phosphatidylinositol N-acetylglucosaminyltransferase subunit H; Fragment; | PIGH; | NULL | 137 | human |
| G3V2I9 | Protein NDRG2; Fragment; | NDRG2; | NULL | 252 | human |
| A0A024R332 | Ngg1 interacting factor 3 like 1 binding protein 1, isoform CRA_a; | NIF3L1BP1; | NULL | 204 | human |
| A0A024R8K0 | Archaemetzincins-2, isoform CRA_d; | AMZ2; | NULL | 360 | human |
| A0A024R8C6 | ST6 (Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, isoform CRA_b; | ST6GALNAC6; | NULL | 299 | human |
| X5D789 | Vasopressin V1a receptor; Fragment; | AVPR1A; | NULL | 382 | human |
| A0A024R7H6 | Zinc finger protein 433, isoform CRA_b; | ZNF433; | NULL | 638 | human |
| A0A024R6G7 | HCG1785399, isoform CRA_a; | NULL | NULL | 173 | human |
| A0A024RCN3 | Lymphocyte antigen 6 complex, locus G5B, isoform CRA_a; | LY6G5B; | NULL | 146 | human |
| X6RL62 | Metalloendopeptidase OMA1, mitochondrial; Fragment; | OMA1; | NULL | 253 | human |
| H0YGF2 | Probable cysteine--tRNA ligase, mitochondrial; Fragment; | CARS2; | NULL | 92 | human |
| A0A024R333 | Transmembrane protein 113, isoform CRA_a; | TMEM113; | NULL | 313 | human |
| A0A024R089 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa, isoform CRA_a; | TAF13; | NULL | 124 | human |
| A0A024R4K3 | Malate dehydrogenase; EC 1.1.1.37; | MDH2; | NULL | 338 | human |
| M0R1X0 | tRNA modification GTPase GTPBP3, mitochondrial; | GTPBP3; | NULL | 151 | human |
| A0A024RDV2 | HCG32190, isoform CRA_b; | NULL | NULL | 583 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |